Kartik Subramanian

Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity

Marc Hafner, Caitlin E. Mills, Kartik Subramanian et al. · Cell chemical biology · 2019 · 244 citations · Full text

Drug Target, Engineering, Translational Bioinformatics +10

From word models to executable models of signaling networks using automated assembly

Benjamin M. Gyori, John A. Bachman, Kartik Subramanian et al. · Molecular Systems Biology · 2017 · 175 citations · Full text

A Multi-center Study on the Reproducibility of Drug-Response Assays in Mammalian Cell Lines

Mario Niepel, Marc Hafner, Caitlin E. Mills et al. · Cell Systems · 2019 · 138 citations · Full text

Spheroid Culture for Enhanced Differentiation of Human Embryonic Stem Cells to Hepatocyte-Like Cells

Kartik Subramanian, Derek Jason Owens, Ravali Raju et al. · Stem Cells and Development · 2013 · 76 citations

Cytochrome P450 Activities, Cell Culture, Cell Differentiation +26

Human Embryonic and Rat Adult Stem Cells with Primitive Endoderm-Like Phenotype Can Be Fated to Definitive Endoderm, and Finally Hepatocyte-Like Cells

Philip Roelandt, Karen Pauwelyn, Pau Sancho‐Bru et al. · PLoS ONE · 2010 · 74 citations · Full text